Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34âºCXCR4⺠cells in patients with type 2 diabetes.
Endocrine
; 50(3): 659-64, 2015 Dec.
Article
in En
| MEDLINE
| ID: mdl-26209038
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Dipeptidyl-Peptidase IV Inhibitors
/
Endothelial Progenitor Cells
/
Sitagliptin Phosphate
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Endocrine
Journal subject:
ENDOCRINOLOGIA
Year:
2015
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos